Drug Eruption and Interactions - PHARMACEUTICAL REVIEW
Drug Eruption and Interactions - PHARMACEUTICAL REVIEW Drug Eruption and Interactions - PHARMACEUTICAL REVIEW
IMIGLUCERASE Trade name: Cerezyme (Genzyme) Indications: Gaucher’s disease Category: Enzyme Half-life: 3.6–10.4 hours Clinically important, potentially hazardous interactions with: None Reactions Skin Angioedema (
288 IMIPRAMINE Edema Erythema Exanthems (1–6%) (1992): Breathnach SM+, Adverse Drug Reactions and the Skin Blackwell, Oxford, 197 (passim) (1988): Warnock JK+, Am J Psychiatry 145, 425 (6%) (1985): Walter-Ryan WG+, JAMA 254, 357 Exfoliative dermatitis (1992): Breathnach SM+, Adverse Drug Reactions and the Skin Blackwell, Oxford, 197 (passim) Fixed eruption (
- Page 312 and 313: Toxic epidermal necrolysis Urticari
- Page 314 and 315: Reactions Skin Angioedema Erythema
- Page 316 and 317: Reactions Skin Acne (
- Page 318 and 319: Thrombophlebitis *Note: Furosemide
- Page 320 and 321: GANCICLOVIR Trade names: Cymevan; C
- Page 322 and 323: (2002): Baselga J+, J Clin Oncol 20
- Page 324 and 325: (2003): D’Alessandro V+, Clin Ter
- Page 326 and 327: (1996): Merlob P+, Cutis 57, 429 (n
- Page 328 and 329: Hair Hair - alopecia (>2%) Nails Na
- Page 330 and 331: GLYBURIDE Synonyms: glibenclamide;
- Page 332 and 333: (1982): Bailin PL+, Clin Rheum Dis
- Page 334 and 335: Acne (1996): Lee PK+, JAmAcadDermat
- Page 336 and 337: (2006): Bonkovsky HL, AnnInternMed1
- Page 338 and 339: Peripheral edema (>10%) Purpura Urt
- Page 340 and 341: (1984): Binder RL+, J Clin Psychiat
- Page 342 and 343: HEPARIN Trade names: Calcilean; Cal
- Page 344 and 345: (1990): Rogerson SJ+, BMJ 301, 345
- Page 346 and 347: (1991): Vitris M+, Dakar Med 36(1),
- Page 348 and 349: Other Anaphylactoid reactions/Anaph
- Page 350 and 351: Exanthems Exfoliative dermatitis Fi
- Page 352 and 353: HYDROMORPHONE Trade names: Dilaudid
- Page 354 and 355: (1994): Perrot JL+, Ann Dermatol Ve
- Page 356 and 357: Edema (
- Page 358 and 359: (1994): Halpern SM, Arch Dermatol 1
- Page 360 and 361: Mucosal Oral lesions Sialorrhea (
- Page 364 and 365: (2001): Fife KH+, Sex Transm Dis 28
- Page 366 and 367: Herpes simplex (
- Page 368 and 369: (2004): Scheinfeld N, J Drugs Derma
- Page 370 and 371: (2000): Poole PJ+, Cochrane Databas
- Page 372 and 373: Injection-site pain (2006): Moyes V
- Page 374 and 375: (2002): Tothova E+, Neoplasma 49(2)
- Page 376 and 377: (1995): Shinohara K, NEnglJMed333,
- Page 378 and 379: IOPROMIDE Trade name: Ultravist (Be
- Page 380 and 381: ISOCARBOXAZID Trade names: Enerzer;
- Page 382 and 383: ISOSORBIDE Trade name: Ismotic Indi
- Page 384 and 385: Nails Nails - brittle (2001): Önde
- Page 386 and 387: Serum sickness (1998): Park H+, Ann
- Page 388 and 389: (2001): Burstal R+, Anaesth Intensi
- Page 390 and 391: Pruritus (1-10%) Psoriasis (1992):
- Page 392 and 393: LAMIVUDINE Synonym: 3TC Trade names
- Page 394 and 395: (2006): Fix OK+, Clin Gastroenterol
- Page 396 and 397: Eyelashes - ptosis (2005): Casson R
- Page 398 and 399: LETROZOLE Trade name: Femara (Novar
- Page 400 and 401: Other Abdominal pain (2003): Cramer
- Page 402 and 403: Photosensitivity (
- Page 404 and 405: (2002): Kalin JR+, JForensicSci47(5
- Page 406 and 407: (2002): Serratrice J+, Am J Ophthal
- Page 408 and 409: (1981): Hess EV, Arthritis Rheum 24
- Page 410 and 411: Purpura (
IMIGLUCERASE<br />
Trade name: Cerezyme (Genzyme)<br />
Indications: Gaucher’s disease<br />
Category: Enzyme<br />
Half-life: 3.6–10.4 hours<br />
Clinically important, potentially hazardous interactions<br />
with: None<br />
Reactions<br />
Skin<br />
Angioedema (